/Companies

Pulmoqune Therapeutics

San Diego, US · Founded 2020 · Delaware corporation

Find your way into Pulmoqune Therapeutics

Sign up to see every warm intro you have to Pulmoqune Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pulmoqune Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

SS
Sarah Schlesinger, MDNamed on SEC filing
PB
Peter B. FinnNamed on SEC filing
RH
Robert HillmanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5.5M disclosed across 1 round · 2020

▶$5.5MraisedApr 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah Schlesinger, MDDirector
  • Peter B. FinnExecutive Officer
  • Robert HillmanExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
Minimum investment
$500K
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Pulmoqune Therapeutics raised?
Pulmoqune Therapeutics has disclosed $5.5M raised across 1 round.
Where is Pulmoqune Therapeutics headquartered?
Pulmoqune Therapeutics is headquartered in San Diego, US.